Abstract
THE CONVENTIONAL TREATMENT for International Society of Heart and Lung Transplantation (ISHLT) grade 3A acute cardiac allograft rejection (AR) is intravenous steroid therapy. To reduce the total steroid dose and utilize an outpatient environment, low-dose oral prednisone protocols have been developed for AR treatment when the patient does not display significant hemodynamic compromise. This option was not only effective but also associated with fewer side effects and with reduced cost. The aim of the present study was to analyze the results of an outpatient low-dose oral prednisone protocol in AR without hemodynamic compromise.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
